TCI Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-154
| Closed | -$15K | – | 472 |
|
|
2023
Q1 | $15K | Sell |
154
-93
| -38% | -$9.64K | ﹤0.01% | 851 |
|
|
2022
Q4 | $25.6K | Buy |
247
+100
| +68% | +$9.39K | ﹤0.01% | 596 |
|
|
2022
Q3 | $12K | Buy |
147
+7
| +5% | +$623 | ﹤0.01% | 896 |
|
|
2022
Q2 | $12K | Hold |
140
| – | – | ﹤0.01% | 887 |
|
|
2022
Q1 | $11K | Sell |
140
-37
| -21% | -$3.1K | ﹤0.01% | 1024 |
|
|
2021
Q4 | $16K | Buy |
177
+15
| +9% | +$1.24K | ﹤0.01% | 806 |
|
|
2021
Q3 | $13K | Hold |
162
| – | – | ﹤0.01% | 906 |
|
|
2021
Q2 | $14K | Buy |
162
+30
| +23% | +$2.38K | ﹤0.01% | 741 |
|
|
2021
Q1 | $10K | Buy |
132
+72
| +120% | +$5.88K | ﹤0.01% | 843 |
|
|
2020
Q4 | $5K | Hold |
60
| – | – | ﹤0.01% | 851 |
|
|
2020
Q3 | $5K | Hold |
60
| – | – | ﹤0.01% | 751 |
|
|
2020
Q2 | $7K | Hold |
60
| – | – | ﹤0.01% | 645 |
|
|
2020
Q1 | $5K | Hold |
60
| – | – | ﹤0.01% | 699 |
|
|
2019
Q4 | $5K | Hold |
60
| – | – | ﹤0.01% | 839 |
|
|
2019
Q3 | $4K | Hold |
60
| – | – | ﹤0.01% | 851 |
|
|
2019
Q2 | $5K | Hold |
60
| – | – | ﹤0.01% | 753 |
|
|
2019
Q1 | $5K | Hold |
60
| – | – | ﹤0.01% | 772 |
|
|
2018
Q4 | $5K | Hold |
60
| – | – | ﹤0.01% | 754 |
|
|
2018
Q3 | $6K | Hold |
60
| – | – | ﹤0.01% | 734 |
|
|
2018
Q2 | $6K | Hold |
60
| – | – | ﹤0.01% | 728 |
|
|
2018
Q1 | $5K | Hold |
60
| – | – | ﹤0.01% | 724 |
|
|
2017
Q4 | $5K | Hold |
60
| – | – | ﹤0.01% | 769 |
|
|
2017
Q3 | $6K | Hold |
60
| – | – | ﹤0.01% | 688 |
|
|
2017
Q2 | $5K | Hold |
60
| – | – | ﹤0.01% | 742 |
|
|
2017
Q1 | $5K | Hold |
60
| – | – | ﹤0.01% | 704 |
|
|
2016
Q4 | $5K | Buy |
+60
| New | +$5.16K | ﹤0.01% | 761 |
|
|
2016
Q1 | – | Sell |
-6
| Closed | -$1K | – | 1329 |
|
|
2015
Q4 | $1K | Buy |
+6
| New | +$627 | ﹤0.01% | 920 |
|
Other funds holding BMRN
ACA
BBA